Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms
A Double-Blind, Randomized Study of Puncturing Versus Non-Puncturing Acupuncture for the Treatment of Interstitial Cystitis Symptoms
1 other identifier
interventional
60
1 country
1
Brief Summary
Acupuncture is a form of Chinese medicine that has been in existence for more than a thousand years. This clinical trial performs two types of acupuncture on traditional 'bladder' points to determine if one type demonstrates improvement over the other. In the first type needles stimulate acupuncture points on the skin, and in the second type the needles penetrate through the skin similar to how acupuncture is usually performed. The technique is done through shields so that people will not know what type of acupuncture they receive. Patients must have at least moderately severe disease as determined by a urologist. They must be willing not to change their medical regimen for the duration of the trial. Patients will receive twelve treatments over six to twelve weeks. They will be asked to fill out symptom questionnaires and bladder diaries at regular intervals to monitor change. All treatment is free of charge, and patients who complete the trial will receive a small stipend.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Sep 2004
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2004
CompletedFirst Submitted
Initial submission to the registry
October 27, 2004
CompletedFirst Posted
Study publicly available on registry
October 28, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2005
CompletedJune 24, 2005
October 1, 2004
October 27, 2004
June 23, 2005
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of improvement between arms as indicated by a Patient Overall Rating of Improvement Scale
Secondary Outcomes (3)
Improvement in Interstitial Cystitis Symptom and Problem Indices (validated symptom-specific measures)
Improvement in University of Wisconsin-Interstitial Cystitis Scale (validated symptom-specific measure)
Improvement in frequency, urgency and nocturia as measured on bladder diaries
Interventions
Eligibility Criteria
You may qualify if:
- Age 18-65 years
- Symptomatic IC for at least six months
- Urinary frequency of at least eleven voids in a 24 hour period
- A self-rated global discomfort score of 4 or greater on a 0-10 scale
You may not qualify if:
- Medical History or Co-Morbid Conditions:
- Any history of: bladder calculus, tuberculous cystitis; neurological disease or diabetic cystopathy; malignant bladder tumors, urethral cancer
- Prior 3 years of uterine, cervical or vaginal cancer (women only)
- Prior 6-12 weeks of: bacterial urinary tract infection; active genital herpes; gross hematuria
- Concurrent active urethral calculus, ureteral calculus, symptomatic urethral diverticulum; documented chronic bacterial prostatitis (men only); active vaginitis, pregnancy (women only)
- Prior and Concurrent Treatment for IC:
- Any history of: cyclophosphamide, pelvic radiation; augmentation cystoplasty, cystectomy or cystolysis, neurectomy, implanted peripheral nerve stimulator; prostate surgery or treatment (men only)
- In the prior 24 weeks: any treatment with intravesical BCG, cystocele, rectocele, urinary incontinence surgery, transvaginal surgery, hysterectomy, prolapse, vaginal delivery or C-section (women only)
- Prior 6-12 weeks: any treatment by urethral dilatation, cystometrogram, urodynamics, cystoscopy/hydrodistention, bladder biopsy; prostate biopsy (men only); any intravesical treatment other than BCG
- Prior 4 weeks: any new medications initiated for IC
- Concurrent intravesical heparin, chronic use of acetylsalicylic acid, non-steroidal anti-inflammatory drugs or opioid pain medications for another pain condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pennsylvania Pain Medicine Center
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 27, 2004
First Posted
October 28, 2004
Study Start
September 1, 2004
Study Completion
September 1, 2005
Last Updated
June 24, 2005
Record last verified: 2004-10